QT Vascular sells coronary assets to Teleflex for $98.4M

QT Vascular agreed to sell its intellectual property rights for non-drug coated coronary products and an option for a coated product to Teleflex for $98.4 million in cash, plus royalties and supply agreements.

“The proposed sale represents an 'attractive opportunity' for the group to realise the value of its products”straitstimes.com

• 1 source
• straitstimes.comQT Vascular to sell coronary assets to Teleflex for $98.4 million; receive royalties, revenue from supply deals | The Straits TimesAnn WilliamsMay 24, 2018

Summarized from public sources; check the original articles before acting on it.